Dopaminergic receptor-ligand binding assays based on molecularly imprinted polymers on quartz crystal microbalance sensors.

Wanpen Naklua,R. Suedee,P. Lieberzeit

DOI: https://doi.org/10.1016/j.bios.2016.02.047

2016-07-15

Abstract:

What problem does this paper attempt to address?

Treatment Experience of Severe Abdominal Infection after Orthotopic Liver Transplantation

Y-G Wang,J-S Wu,B. Jiang,J-H Wang,C-P Liu,C. Peng,B-Z Tian

DOI: https://doi.org/10.7727/wimj.2014.055

2015-01-01

West Indian Medical Journal

Abstract:This study aims to investigate the causes and treatment experience of severe abdominal infection after orthotopic liver transplantation. Clinical data were retrospectively analysed in perioperative severe abdominal infection of 186 orthotopic liver transplantation cases from March 2004 to November 2011. Among the 186 patients, 16 cases had severe abdominal infection: five cases had bile duct anastomotic leakage-inducing massive hydrops and infection under liver interstice, 10 cases had extensive bleeding of surgical wound leading to massive haematocele and infection around the liver, and one case had postoperative lower oesophageal fistula leakage causing massive hydrops and infection under the left diaphragm. After definite diagnosis, 12 cases underwent surgery within three days, with no death. Among the four cases that underwent surgery three days after diagnosis, one case died of multiple-organ failure five days after abdominal cavity exploration, which was performed 21 days after liver transplantation. Severe abdominal infections after liver transplantation were the most common causes of death in perioperative liver transplantation. Comprehensive treatment with efficacious antibiotics, multiple-organ support, controlled surgical removal of the lesion, and adequate drainage establishment was the key to the entire treatment.
The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.

Bingjue Ye,Shiwei Chen,Huiting Guo,Weiyang Zheng,Guohua Lou,Xue Liang,Yanning Liu,Cheng Zhou,Min Zheng

DOI: https://doi.org/10.4049/jimmunol.2001323

2022-01-01

Abstract:There is no effective treatment for acute liver failure (ALF) except for an artificial liver support system (ALSS) and liver transplant. Bruton tyrosine kinase (Btk) plays important immunoregulatory roles in the inflammatory diseases, but its possible function in ALF remains to be characterized. In this study, we detected the phosphorylation level of Btk in ALF mouse liver and analyzed the protective effects of Btk inhibitor on survival rate and liver damage in ALF mouse models. We measured the expression levels of various inflammatory cytokines in the ALF mouse liver and primary human monocytes. In addition, we examined the expression of the NLRP3 inflammasome in mouse models with or without Btk inhibition. Clinically, we observed the dynamic changes of Btk expression in PBMCs of ALSS-treated patients. Our results showed that Btk was upregulated significantly in the experimental ALF mouse models and that Btk inhibition alleviated liver injury and reduced the mortality in these models. The protective effect of Btk inhibitors on ALF mice partially depended on the suppression of NLRP3 inflammasome signaling. Clinical investigations revealed that the dynamic changes of Btk expression in PBMCs could predict the effect of ALSS treatment. Our work shows that Btk inhibition is an effective therapeutic strategy for ALF. Moreover, Btk is a useful indicator to predict the therapeutic effect of ALSS on liver failure, which might have great value in clinical practice.
Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Ning Zhou,Jianzhou Li,Yimin Zhang,Juan Lu,Ermei Chen,Weibo Du,Jie Wang,Xiaoping Pan,Danhua Zhu,Ying Yang,Yu Chen,Hongcui Cao,Lanjuan Li

DOI: https://doi.org/10.1016/j.jhep.2015.03.018

IF: 25.7

2015-01-01

Journal of Hepatology

Abstract:Background & Aims: Extracorporeal blood purification systems for supportive therapy of liver failure are widely used. We developed a novel blood purification system, named Li's artificial liver system (Li-ALS), which couples low-volume plasma exchange (low-volume PE) with plasma filtration adsorption (PFA). This study aims to evaluate the efficacy of our novel system in pigs with acute liver failure (ALF).Methods: Thirty-two pigs were infused with D-galactosamine (1.3 g/kg) to induce ALF. All animals were equally and randomly divided into four groups: the ALF control group received intensive care, the PFA group underwent five hour plasma recycling filtration and adsorption purification, the low-volume PE group received one hour low-volume PE, and the Li-ALS group underwent one hour low-volume PE, followed by five hour PFA. Intervention was initiated 36 hours after drug administration. The efficacy of each treatment was assessed by survival time and improvement in hematological, biochemical, and immunohistological parameters.Results: Pigs in the Li-ALS group survived longer than those in the other groups (p < 0.001, ALF control: 60 +/- 2 h; PFA group: 74 +/- 2 h; low-volume PE group: 75 +/- 2 h; and Li-ALS group: 90 +/- 3 h). Liver enzyme, bilirubin, bile acid and blood ammonia levels were decreased significantly after Li-ALS treatment, and increases in inflammatory cytokines were ameliorated. A higher hepatocyte regeneration index was also observed in the Li-ALS group.Conclusion: Our novel Li-ALS could expedite liver regeneration and improve survival time; hence, it could be promising for treating ALF. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B. V. All rights reserved.
Septic shock after liver transplantation successfully treated with endotoxin and cytokine adsorption continuous renal replacement therapy: a case report and literature review

Yining Li,Linshan Zhou,Lingzhi Yang,Fang Yuan

DOI: https://doi.org/10.1177/0300060520940439

Abstract:Endotoxins and cytokines play an important role in multiple organ failure pathogenesis in patients with severe Gram-negative bacterial infection. We present a clinical case where an oXiris hemofilter was used for continuous renal replacement therapy (CRRT) treatment in a patient with septic shock after liver transplantation. A 35-year-old man with a 20-year history of hepatitis B presented with jaundice, loss of appetite, and decreased urine output. He was diagnosed with decompensated cirrhosis with acute-on-chronic liver failure, and liver transplantation was indicated. The day after surgery, he developed hyperthermia, hypotension, anuria, and a progressive increase in blood inflammatory markers and creatinine. Combined with the donor source and blood culture results, septic shock after transplantation was considered. The patient was immediately treated with endotoxin and cytokine adsorption CRRT (oXiris hemofilter) with tigecycline, caspofungin, and ganciclovir as anti-infectives. After 48 hours on CRRT, his blood pressure gradually stabilized, the CLIF Consortium Acute-on-Chronic Liver Failure score decreased from 63 to 43. Procalcitonin, endotoxin, and the inflammatory factors interleukin (IL)-6 and IL-10 also decreased gradually. The patient's liver and kidney functions were completely restored. Our experience suggests that oXiris CRRT combined with antibacterial therapy is an effective treatment for septic shock after liver transplantation.
A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

Qi Xia,Xiahong Dai,Jianrong Huang,Xiaowei Xu,Qian Yang,Xiaoli Liu,Yuemei Chen,Lanjuan Li

DOI: https://doi.org/10.5301/ijao.5000341

2014-01-01

Abstract:Introduction Liver failure is one of the most deadly, prevalent, and costly diseases worldwide. Non-bioartificial liver support systems (NBALs) have been shown to be effective in improving the clinical symptoms and laboratory parameters of patients with liver failure. The main aim of this large case series analysis was to investigate the status of NBALs and their effectiveness in improving survival in liver-failure patients. Methods In this retrospective study, 460 patients with liver failure who received NBAL treatment in addition to conventional medications were compared with 422 patients who were treated with conventional medications alone. Kaplan-Meier and life table analyses were used to estimate survival rates. Results Clinical outcomes were improved after NBAL treatment. The 30-day survival rates of subacute liver failure (SALF) patients were 63% among those who received NBALs and 21% among those who did not receive NBALs (p<0.01). Similarly, the 30-day survival rate of acute-on-chronic liver failure (ACLF) patients who received NBALs was 47%, significantly higher than that of the non-NBAL patients (p<0.05). The survival rates of ACLF patients with low Model for End-Stage Liver Disease (MELD) scores (MELD≤20) were 64% and 40% among whom received NBALs and those who did not, respectively (p<0.01). Conclusions NBAL treatment is helpful to improve the survival of patients with ALF, SALF or ACLF. ACLF patients with lower MELD scores showed improved outcomes relative to those with higher MELD scores.
A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Jiajia Chen,Jianrong Huang,Yuemei Chen,Yinfeng Lu,Lanjuan Li

DOI: https://doi.org/10.5754/hge12025

2012-01-01

Abstract:BACKGROUND/AIMS:To focus on determining efficacy and safety of the combined artificial liver in treating severe hepatitis. METHODOLOGY:Ten patients with acute and chronic severe hepatitis were chosen for this study. A total of 19 cases were treated with a combination of selective plasma absorption and selective plasma exchange and 1 was treated with plasma perfusion absorption. Clinical symptoms and physical signs were observed. In addition, the changes in biochemical markers, coagulation function, and aminogram before and after selective plasma perfusion absorption treatment were compared. RESULTS:Ten patients were able to tolerate the treatment; 8 patients were cured or improved whereas 2 worsened. Statistically significant differences (p<0.05) were observed in the serum levels of total bilirubin, direct bilirubin, indirect bilirubin, alanine transaminase, aspartate transaminase, alkaline phosphatase, total bile acids, albumin and globulin before and after the selective perfusion absorption treatment. In contrast, no statistically significant differences (p>0.05) were observed in the serum concentrations of potassium, sodium, creatinine and urea nitrogen, as well as in prothrombin time, partial thromboplastin time and aminogram changes. CONCLUSIONS:The new perfusion absorber can markedly improve hepatic function without influencing the metabolism of micro-molecules and coagulation factors.
Severe Hepatitis Treated with an Artificial Liver Support System

L Lanjuan,Y Qian,H Jianrong,X Xiaowei,C Yuemei,C Yagang,M Weihang,C Zhi,F Suzhen

DOI: https://doi.org/10.1177/039139880102400508

2001-01-01

The International Journal of Artificial Organs

Abstract:We designed an artificial liver support system (ALSS) including plasma exchange, charcoal hemoperfusion, plasma bilirubin absorption, charcoal plasma perfusion, hemofiltration and hemodialysis. We chose different methods or their combinations according to the patients’ conditions. We investigated the effect of ALSS in 154 patients with severe hepatitis, 72 of whom survived. All data were analyzed by SPSS. The effectiveness of ALSS treatment was compared at different stages (i.e. early, middle and end stages). After each ALSS treatment, the liver function of these patients greatly improved, serum endotoxin and HBV-DNA concentrations were significantly decreased, and the serum concentration of aromatic amino acids (AAA) such as methionine decreased while BCAA/AAA ratio increased. Patients treated with ALSS in the early or middle stages of disease had much higher survival rates than patients in the end stage of disease. Thus, we concluded that ALSS is a reliable therapy for advanced liver diseases and treatment in early or middle stages is appropriate.
Study of Ascitic-Concentrated Bacteria-Filtered Intravenous Re-Transfusion (ABR) to Treat Patients with Peritonitis of Schistosoma Cirrhosis

黄建荣,李兰娟,陈亚岗,徐小微,陈月美,杨芊

DOI: https://doi.org/10.3969/j.issn.1671-4091.2002.11.005

2002-01-01

Abstract:Objective To study the effects and mechanism of ABR to treat patients with peritonitis of Schistosoma cirrhosis.Methods 5 cases of peritonitis of Schistosoma cirrhosis were treated with ABR for 8 times in our hospital.The changes of liver functions,electrolytes,clinical symptoms and signs of these patients were carefully observed before and after each treatment.The concentrations of protein,cells and endotoxin of ascitic fluid were also elevated each time.Results The clinical symptoms such as abdominal distension,lost of appetite were improved obviously.The abdomen circurference and body temperature of these patients were decreased.The blood ration of albumin and globulin of liver function increased from (1.15+0.37)g/dl to (1.31 +0.4)g/dl,as well as the albumin concentration increased from (3.1 +0.7)g/dl to (3.5 + 1.2)g/dl.The situations of kaliopenia,hyponatremia were also improved.The re - transfusion ascites contained increased protein concentration,decreased cell member,normal endotoxin and no bacteria.Conclusion ABR is an effective method to treat refractory ascites and has slight side effect.
Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

Jia-Jia Chen,Jian-Rong Huang,Qian Yang,Xiao-Wei Xu,Xiao-Li Liu,Shao-Rui Hao,Hui-Fen Wang,Tao Han,Jing Zhang,Jian-He Gan,Zhi-Liang Gao,Yu-Ming Wang,Shu-Mei Lin,Qing Xie,Chen Pan,Lan-Juan Li

DOI: https://doi.org/10.1016/s1499-3872(16)60084-x

IF: 3.355

2016-01-01

Hepatobiliary & Pancreatic Diseases International

Abstract:BACKGROUND:Plasma exchange (PE)-centered artificial liver support system reduced the high mortality rate of hepatitis B virus (HBV)-related acute-on-chronic liver failure (ACLF). But the data were diverse in different medical centers. The present prospective nationwide study was to evaluate the effects of PE on patients with HBV-ACLF at different stages.METHODS:From December 2009 to December 2011, we evaluated 250 patients at different stages of HBV-ACLF from 10 major medical centers in China. All the laboratory parameters were collected at admission, before and after PE.RESULTS:Among the 250 patients who underwent 661 rounds of PE, one-month survival rate was 61.6%; 141 (56.4%) showed improvement after PE. Variables such as age (P=0.000), levels of total bilirubin (TB, P=0.000), direct bilirubin (P=0.000), total triglycerides (P=0.000), low-density lipoprotein (P=0.022), Na+ (P=0.014), Cl- (P=0.038), creatinine (Cr, P=0.007), fibrinogen (P=0.000), prothrombin time (PT, P=0.000), white blood cell (P=0.000), platelet (P=0.003) and MELD (P=0.000) were significantly related to prognosis. Multivariate logistic regression analysis showed that age, disease stage, TB, Cr and PT levels were independent risk factors of mortality among HBV-ACLF patients.CONCLUSIONS:PE can improve the clinical outcome of patients with HBV-ACLF. Levels of TB, Cr and PT, age and disease stage help to predict prognosis.
Microbial Infections As A Trigger For Acute-Onchronic Liver Failure: A Review

Qun Cai,Wei Liu,Mingyan Zhu,Jifang Sheng

DOI: https://doi.org/10.12659/MSM.915637

2019-01-01

Medical Science Monitor

Abstract:Microbial infection is an important cause of acute-on-chronic liver failure (ACLF), which is a syndrome that results in multiple organ dysfunction or failure and is accompanied by an increased short-term risk of mortality. Early detection and treatment of microbial infection can effectively reduce the mortality of patients with ACLF. However, antimicrobial resistance has recently increased due to the increased use of antimicrobial agents. Therefore, it is important to choose appropriate antibiotics and antifungal agents for early prevention or treatment of patients with microbial infection and ACLF to reduce the occurrence of drug resistance and to reduce patient mortality. This review summarizes the current status in the understanding of the epidemiology, pathogenesis, early diagnosis, treatment, and strategies for prevention of microbial infection in patients with ACLF.
Untoward hematologic responses to the antithyroid compounds.

T. H. Mcgavack,J. Chevalley

DOI: https://doi.org/10.1016/0002-9343(54)90141-2

1954-07-01

Abstract:
Clostridium perfringens-induced massive hemolysis treatment with blood purification to target toxins: a case report

I Reffo,M Domini,M Cevolani,G Del Fabro,D Rufolo,S Venturini,L Pinciroli,D Tonin,M Avolio,M Crapis,G Basaglia,M Balbi,G Nadalin

DOI: https://doi.org/10.1007/s13730-024-00857-3

Abstract:Clostridium perfringens can rarely cause severe systemic infections, usually from an abdominal source, associated with massive hemolysis, which is usually fatal. Hemolytic anemia and acute renal injury resulting from toxin action are critical for the development of multiple organ dysfunction syndrome (MODs), making this condition a real emergency, requiring multispecialty skills and aggressive multimodal therapies. We herein describe a case of septic shock from acute cholecystitis with massive hemolysis caused by C. perfringens in a 55 year-old man that was successfully treated with early blood purification and continuous renal replacement therapy (CRRT) along with antibiotic therapy and surgery. The effect of the enormous amount of toxins produced by Clostridium which elicit a strong cytokine response and the damage caused by the hemolysis products are the main pathogenetic mechanisms of this rare but lethal clinical entity. The main goal of treatment is to remove toxins from plasma, block toxin action, and further production by achieving bacterial killing with antimicrobial agents and controlling the infectious focus, remove waste products and prevent or limit multiorgan damage. Blood purification techniques play an important role due to a strong pathophysiological rationale, as they can remove toxins and cytokines as well as cell-free products from plasma and also replace renal function. Although this condition is rare and robust data are lacking, blood purification techniques for C. perfringens-induced massive hemolysis are promising and should be further explored.
Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure

Yanping Xiang,Renhua Li,Jia Cai,Qian Jiang

DOI: https://doi.org/10.2147/TCRM.S485620

2024-10-25

Abstract:Background: This study aimed to investigate clinical efficacy, safety and short-term prognosis of plasma exchange (PE), plasma perfusion combining PE (PP+PE), dual-plasma molecular adsorption system combining PE (DPMAS+PE) in treating acute-on-chronic liver failure (ACLF). Methods: Two hundred and fourteen ACLF patients admitted to our hospital were included and divided into PE (n = 72), PP+PE (n = 75), DPMAS+PE group (n = 67). Laboratory indexes and MELD scores were collected, and clinical efficacy was compared. Patients' adverse reactions during and 24-h after treatment were collected, and safety was compared. Survival status of patients was followed-up within 90 days, and prognosis was analyzed. Results: PE, PP+PE and DPMAS+PE significantly reduce TBiL, DBiL, ALT, AST, SA, PT, INR, PCT and CRP levels, and increase PA and PTA levels, compared with pre-treatments (P < 0.05). WBC and SCR levels in DPMAS+PE group decreased significantly post-treatment (P < 0.05). Na+ and Cl- levels in PE and PP+PE group decreased significantly post-treatment (P < 0.05). Total adverse reaction incidence in PE, PP+PE, DPMAS+PE group were 38.89%, 22.70%, 17.90%, respectively, with significant differences among three groups (P < 0.05). Ninety-day mortality rates of patients in PE, PP+PE, DPMAS+PE group were 41.67%, 34.67%, 20.90%, respectively, with significant differences among three groups (P < 0.05). Conclusion: PE, PP+PE and DPMAS+PE three artificial liver treatment modes can effectively improve liver, kidney and coagulation function of ACLF patients. DPMAS+PE demonstrated better ability to remove endotoxin and inflammatory mediators, showed advantages in reducing ACLF patient mortality within 90 days, and had the least impact on electrolyte post-treatment. Therefore, DPMAS+PE can be used as a better choice for clinical treatment.
Blood Purification for Adult Patients With Severe Infection or Sepsis/Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials

Jia-Jin Chen,Pei-Chun Lai,Tao-Han Lee,Yen-Ta Huang

DOI: https://doi.org/10.1097/CCM.0000000000005991

2023-12-01

Abstract:Objectives: This study aimed to conduct a comprehensive and updated systematic review with network meta-analysis (NMA) to assess the outcome benefits of various blood purification modalities for adult patients with severe infection or sepsis. Data sources: We conducted a search of PubMed, MEDLINE, clinical trial registries, Cochrane Library, and Embase databases with no language restrictions. Study selection: Only randomized controlled trials (RCTs) were selected. Data extraction: The primary outcome was overall mortality. The secondary outcomes were the length of mechanical ventilation (MV) days and ICU stay, incidence of acute kidney injury (AKI), and kidney replacement therapy requirement. Data synthesis: We included a total of 60 RCTs with 4,595 participants, comparing 16 blood purification modalities with 17 interventions. Polymyxin-B hemoperfusion (relative risk [RR]: 0.70; 95% CI, 0.57-0.86) and plasma exchange (RR: 0.61; 95% CI, 0.42-0.91) were associated with low mortality (very low and low certainty of evidence, respectively). Because of the presence of high clinical heterogeneity and intransitivity, the potential benefit of polymyxin-B hemoperfusion remained inconclusive. The analysis of secondary outcomes was limited by the scarcity of available studies. HA330 with high-volume continuous venovenous hemofiltration (CVVH), HA330, and standard-volume CVVH were associated with shorter ICU stay. HA330 with high-volume CVVH, HA330, and standard-volume CVVH were beneficial in reducing MV days. None of the interventions showed a significant reduction in the incidence of AKI or the need for kidney replacement therapy. Conclusions: Our NMA suggests that plasma exchange and polymyxin-B hemoperfusion may provide potential benefits for adult patients with severe infection or sepsis/septic shock when compared with standard care alone, but most comparisons were based on low or very low certainty evidence. The therapeutic effect of polymyxin-B hemoperfusion remains uncertain. Further RCTs are required to identify the specific patient population that may benefit from extracorporeal blood purification.
Combined Treatment with MSC Transplantation and Neutrophil Depletion Ameliorates D-GalN/LPS-induced Acute Liver Failure in Rats.

Xin Zhao,Xiaolei Shi,Zhiheng Zhang,Hucheng Ma,Xianwen Yuan,Yitao Ding

DOI: https://doi.org/10.1016/j.clinre.2016.04.003

IF: 3.189

2016-01-01

Clinics and Research in Hepatology and Gastroenterology

Abstract:Background: The imbalance of immunity is an important pathogenesis of acute liver failure (ALF). Neutrophils are the hallmark of acute inflammation, which have an essential role in immune regulation. Mesenchymal stem cell (MSC) transplantation is a promising therapy in ALF treatment. Recent studies indicated a considerable connection between MSCs and neutrophils in immune regulation. Aim: To investigate changes in neutrophils in ALF rats after MSC transplantation, and to explore the therapeutic effect and mechanism of the combined treatment with MSC transplantation and neutrophil depletion in ALF.Methods: We employed monotherapy and the combination therapy with MSCs and anti-PMN serum in D-galactosamine (D-GalN)/lipopolysaccharides (LPS)-induced ALF rats. Rats were sacrificed at 6, 12 and 24 h, respectively. Blood samples and liver tissues were collected. Hepatic injury, inflammatory cytokines (TNF-alpha, IL-1 beta and IL-10), chemokines (CXCL1 and CXCL2), the number and activity of neutrophils and animal survival were assessed at fixed times.Results: MSC transplantation can effectively improve the liver function of ALF rats and reduce the number and activity of neutrophils in both peripheral blood and liver. Compared with MSC transplantation alone, anti-PMN treatment and co-treatment had a better result in diminishing neutrophils. The co-treatment also exhibited a better therapeutical effect in ALF rats compared with monotherapy. In this process, the expressions of inflammatory cytokines in the liver were consistent with liver function.Conclusions: The regulation of the neutrophil-related microenvironment is affected in DGalN/LPS-induced ALF rats after MSC transplantation. The combined treatment with MSC transplantation and neutrophil depletion may have a better therapeutic effect in ALF rats. (C) 2016 Published by Elsevier Masson SAS.
Liver Transplantation for Acute-on-Chronic Liver Failure Associated with Acute Necrotizing Pancreatitis: A Case Report

Zhe Yang,Kai Wun Chang,Xiang Yan Liu,Li Zhuang,Shuo Wang,Shu-Sen Zheng

DOI: https://doi.org/10.1016/j.transproceed.2021.02.008

IF: 1.014

2021-01-01

Transplantation Proceedings

Abstract:Liver transplantation (LT) for acute-on-chronic liver failure (ACLF) accompanied by acute necrotizing pancreatitis is still unclear. We have a reported case of LT for ACLF associated with acute necrotizing pancreatitis. The postoperative multiorgan dysfunction and secondary infection were successfully managed under close supervision. The patient was a 47-year-old man with chronic hepatitis B virus infection presented with ACLF and acute necrotizing pancreatitis. After receiving LT from a deceased donor, the patient's liver functioning rapidly reverted to a normal level, and the acute pancreatitis was simultaneously stabilized. However, the patient later developed multiorgan dysfunction secondary to multidrug resistant bacteria infection, which was treated successfully with repeated percutaneous drainage, sensitive antibiotics, continuous renal replacement therapy, microbial balance, and best supportive care. LT can be considered for ACLF associated with acute necrotic pancreatitis without absolute contraindication. Moreover, we recommend a close observation of possible postoperative severe infection, and cautious multidisciplinary management was needed for the prevention of organ dysfunction.
Efficacy Evaluation of Continuous Blood Purification in the Treatment of Severe Sepsis Patients

Wu-han LI,Ri-sheng ZHAO,Yun-zhao ZHAO

DOI: https://doi.org/10.16662/j.cnki.1674-0742.2015.13.012

2015-01-01

Abstract:Objective To analysis the continuous blood purification in the treatment of severe sepsis patients clinical curative ef-fect, for clinical provides the basis for using blood purification in the treatment of sepsis, and provide effective treatment for patients with severe sepsis. Methods From April to 2014 in our department in 2013 December were treated 90 cases of intestinal fistula abdominal infection in patients with severe sepsis as the research object, the random were divided into observation group and con-trol group, control group implement routine therapy, observation group in the control group based on the implementation of contin-uous blood purification treatment, compared two groups of vital signs in patients with body temperature, heart rate, blood pressure and respiratory frequency and interleukin - 8 and the change of tumor necrosis factor alpha. Results The observation group than control group in the vital signs of body temperature, heart rate, blood pressure and respiratory frequency and interleukin - 8 and improve the tumor necrosis factor alpha, difference have statistical significance (P<0.05). Conclusion Continuous blood purification treatment of patients with severe sepsis clinical curative effect significantly, can significantly improve the patient's recovery.
Therapeutic Effect of Continuous Blood Purification Combined with Humanized Nursing in Patients with Severe Sepsis

Lili Gan,Jiafeng Hu,Li Xia,Xiaoqin Xi

DOI: https://doi.org/10.1155/2022/1411371

2022-08-18

Abstract:This work aimed to explore the effect of humanized nursing on the patients' recovery from severe sepsis based on continuous blood purification (CBP). 90 patients with severe sepsis were randomly and equally divided into a control group (basic intensive nursing + CBP) and a therapy group (humanized nursing + CBP). Before treatment and on the 7th and 14th days after treatment, indicators of patients were compared, including white blood cell (WBC), tumor necrosis factor (TNF-α), hepatic and renal function, C-reactive protein (CRP), brain natriuretic peptide (BNP), procalcitonin (PCT), and erythrocyte sedimentation rate (ESR). The mortality and nursing satisfaction were compared. After treatment, the saturation of pulse oxygen (SPO2) in the therapy group (85 ± 20 and 91 ± 9) was higher than that in the control group (78 ± 28 and 82 ± 18, respectively), and the lactic acid level (LAL) was greatly lower (2.8 ± 2.4 and 1.6 ± 0.9 vs. 4.3 ± 2.3 and 2.3 ± 2.7). The Acute Physiology and Chronic Health Evaluation II (APACHE-II) score after treatment was lower (13.67 ± 4.28 and 8.45 ± 5.12 vs. 17.34 ± 6.4 and 11.46 ± 4.23). The BNP, blood urea nitrogen (BUN), and CRP levels were decreased, and so did inflammatory indicators. The survival rate reached 71% and 47% in the therapy group and control group, respectively; and the nursing satisfaction was 97.80% and 26.67%, respectively. Humanized nursing combined with CBP could improve the therapeutic effect and speed up the recovery from severe sepsis.

integrative & complementary medicine
IS THERE BIAS IN THE PUBLICATION OF INDIVIDUAL PATIENT DATA META-ANALYSES?

J. Tierney,M. Clarke,L. Stewart

DOI: https://doi.org/10.1017/S0266462300101217

2000-04-01

International Journal of Technology Assessment in Health Care

Abstract:Objective: There is increasing empirical evidence for the existence of bias in the publication of primary clinical research, with statistically significant results being published more readily, more quickly, and in higher impact journals. Meta-analysis of individual patient data (IPD) may represent a gold standard of “secondary” clinical research, giving the best possible summary of current evidence for a particular question, but publication of these may also be subject to bias. This study aimed to explore which factors might be associated with publication of IPD meta-analyses and to identify potential sources of bias. Methods: For all known IPD meta-analysis projects in cancer, the responsible investigator was surveyed by means of a questionnaire to determine descriptive characteristics of the meta-analysis, the nature of the results, and details of the publication history. Results: There is no good evidence that overall publication status of meta-analyses in cancer is dependent on the statistical or clinical significance of the results. However, those meta-analyses with nonsignificant results did seem to take longer to publish and were published in lower impact journals compared with those with more striking results. Conclusions: Based on the current data, there seems to be no strong association between the results of IPD meta-analyses in cancer and publication.
[Infectious diseases under prolonged corticotherapy (194 cases including 102 of chickenpox)].

J. Gerbeaux,J. Couvreur,A. BACULARD-BEAUCHEF,J. Joly

1963-01-08

Abstract:

Dopaminergic receptor-ligand binding assays based on molecularly imprinted polymers on quartz crystal microbalance sensors.

Treatment Experience of Severe Abdominal Infection after Orthotopic Liver Transplantation

The Inhibition of Bruton Tyrosine Kinase Alleviates Acute Liver Failure via Downregulation of NLRP3 Inflammasome.

Efficacy of Coupled Low-Volume Plasma Exchange with Plasma Filtration Adsorption in Treating Pigs with Acute Liver Failure: A Randomised Study.

Septic shock after liver transplantation successfully treated with endotoxin and cytokine adsorption continuous renal replacement therapy: a case report and literature review

A Single-Center Experience of Non-Bioartificial Liver Support Systems among Chinese Patients with Liver Failure

A Clinical Study on the Treatment of Severe Hepatitis by a Combined Artificial Liver.

Severe Hepatitis Treated with an Artificial Liver Support System

Study of Ascitic-Concentrated Bacteria-Filtered Intravenous Re-Transfusion (ABR) to Treat Patients with Peritonitis of Schistosoma Cirrhosis

Plasma Exchange-Centered Artificial Liver Support System in Hepatitis B Virus-Related Acute-on-chronic Liver Failure: a Nationwide Prospective Multicenter Study in China.

Microbial Infections As A Trigger For Acute-Onchronic Liver Failure: A Review

Untoward hematologic responses to the antithyroid compounds.

Clostridium perfringens-induced massive hemolysis treatment with blood purification to target toxins: a case report

Three Artificial Liver Models of Treatment of Acute-on-Chronic Liver Failure

Blood Purification for Adult Patients With Severe Infection or Sepsis/Septic Shock: A Network Meta-Analysis of Randomized Controlled Trials

Combined Treatment with MSC Transplantation and Neutrophil Depletion Ameliorates D-GalN/LPS-induced Acute Liver Failure in Rats.

Liver Transplantation for Acute-on-Chronic Liver Failure Associated with Acute Necrotizing Pancreatitis: A Case Report

Efficacy Evaluation of Continuous Blood Purification in the Treatment of Severe Sepsis Patients

Therapeutic Effect of Continuous Blood Purification Combined with Humanized Nursing in Patients with Severe Sepsis

IS THERE BIAS IN THE PUBLICATION OF INDIVIDUAL PATIENT DATA META-ANALYSES?

[Infectious diseases under prolonged corticotherapy (194 cases including 102 of chickenpox)].